hept-4-yne-1,2-diol | 89897-10-9

• 分子结构分类: 有机化合物 - 脂质和类脂质分子 - 脂肪酰基
• 英文名称: hept-4-yne-1,2-diol
• 英文别名: 1.2-Dihydroxy-heptin-(4)；Hept-4-yne-1,2-diol
• CAS: 89897-10-9
• 化学式: C₇H₁₂O₂
• 分子量: 128.171
• InChiKey: VBISXPNJKXFPBT-UHFFFAOYSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  0.4
• 重原子数：
  9
• 可旋转键数：
  2
• 环数：
  0.0
• sp3杂化的碳原子比例：
  0.71
• 拓扑面积：
  40.5
• 氢给体数：
  2
• 氢受体数：
  2

反应信息

• 作为反应物：
  描述：

  hept-4-yne-1,2-diol 在 sodium periodate 作用下， 生成 hex-3-ynal
  参考文献：
  名称：

  Sur les ald�hydes ?-ac�tyl�niques Synth�se de l'hexyne-3-al

  摘要：

  Abstractβ‐Hexynal and some of its derivatives have been prepared.

  DOI：

  10.1002/hlca.19630460530
• 作为产物：
  描述：

  1-庚烯-4-炔 生成 hept-4-yne-1,2-diol
  参考文献：
  名称：

  Odeur et《宪法》。XX。合成DES顺-等反式己烯-3-人

  摘要：

  描述了纯顺式和反式-3-己烯醛的合成。结果表明，早先报道的3-己烯醛或β-己烯醛的制备物在大多数情况下导致了异构体2-己烯醛。

  DOI：

  10.1002/hlca.19620450726

文献信息

• Hydrogenation Promoter, Hydrogenation Catalyst, and Process for Producing Alkene Compound
  申请人：Hori Junichi

  公开号：US20080033221A1

  公开（公告）日：2008-02-07

  A hydrogenation promoter of the present invention is produced by reacting an alkyne compound or an alkene compound, a palladium compound represented by a general formula Pd(II)X j L k (where L represents a monodentate ligand or a polydendate ligand other than a phosphorus-containing ligand (when two or more Ls are present in the compound, the Ls may be the same or different), X represents an anionic group, j represents a value determined according to the valence of X so that X j has a valence of −2 as a whole, and k represents an integer in the range of 0 to 4), and a base in an organic solvent. Specifically, The hydrogenation promoter of the invention includes palladium nanoparticles containing the alkyne compound or the alkene compound as an agglomeration-preventing agent.

  本发明的氢化促进剂是通过在有机溶剂中反应炔烃化合物或烯烃化合物、由一般式Pd(II)XjLk表示的钯化合物(其中L表示单齿配体或不含磷的多齿配体（当化合物中存在两个或两个以上的L时，L可以相同也可以不同），X表示阴离子基团，j表示根据X的价确定的值，使Xj整体价为-2，k表示0到4之间的整数)，以及碱的反应产生的。具体来说，本发明的氢化促进剂包括含有炔烃化合物或烯烃化合物作为凝聚抑制剂的钯纳米粒子。
• ANTISPASMODIC 1,2-DIOLS AND 1,2,3-TRIOLS
  申请人：Prima Innovations LLC

  公开号：EP2854782A1

  公开（公告）日：2015-04-08
• US7619125B2
  申请人：——

  公开号：US7619125B2

  公开（公告）日：2009-11-17
• [EN] ANTISPASMODIC 1,2-DIOLS AND 1,2,3-TRIOLS<br/>[FR] 1,2-DIOLS ET 1,2,3-TRIOLS ANTISPASMODIQUES
  申请人：PRIMA INNOVATIONS LLC

  公开号：WO2013181084A1

  公开（公告）日：2013-12-05

  The present invention is directed to pharmaceutical compositions comprising antispasmodic C4-C8aliphatic-l,2-diols and C4-C8aliphatic-l,2,3-triols and their use to relieve the spasms associated with pain. These agents may be administered topically or orally and may be combined with anti-inflammatory agents such as a non-steroidal anti-inflammatory drug or a corticosteroid. Administration of the C4-C8aliphatic-l,2-diols and C4-C8aliphatic-l,2,3-triols with vitamin D3 is indicated for conditions such as bone loss, weight gain and autoimmune diseases such as lupus and rheumatoid arthritis.
• Sur les ald�hydes ?-ac�tyl�niques Synth�se de l'hexyne-3-al
  作者：M. Winter

  DOI：10.1002/hlca.19630460530

  日期：——

  Abstractβ‐Hexynal and some of its derivatives have been prepared.